Tapering Duloxetine 60 mg and Switching to Wellbutrin (Bupropion)
Taper duloxetine gradually over 1-2 weeks by reducing to 30 mg daily for at least one week before discontinuation, then initiate bupropion at 150 mg once daily for 3 days before increasing to the target dose of 150 mg twice daily (maximum 300 mg/day). This approach minimizes withdrawal symptoms while establishing therapeutic levels of the new medication.
Duloxetine Discontinuation Strategy
SNRIs like duloxetine require slow tapering to prevent discontinuation syndrome 1. The evidence clearly indicates that:
Avoid alternate-day dosing - Recent research demonstrates that dosing antidepressants every other day during tapering causes pronounced receptor occupancy variation and significantly increases withdrawal symptom risk 2. This strategy cannot be recommended.
Use gradual dose reduction - Reduce from 60 mg to 30 mg daily for a minimum of 1 week before complete discontinuation 3. Duloxetine has a sufficiently long elimination half-life to permit once-daily dosing 1.
Monitor for withdrawal symptoms including dizziness, nausea, headache, irritability, insomnia, and sensory disturbances. These typically emerge within days of dose reduction or discontinuation 1.
Bupropion Initiation Protocol
Follow FDA-approved dosing from the Wellbutrin label 4:
- Days 1-3: 150 mg once daily in the morning
- Day 4 onward: 150 mg twice daily (total 300 mg/day) if tolerated
- Maximum dose: 300 mg/day for standard formulations
Key safety considerations:
- Bupropion is contraindicated in patients with seizure disorders, brain metastases, or eating disorders due to increased seizure risk 5, 4
- Do not combine with MAO inhibitors - allow 14 days between discontinuing an MAOI and starting bupropion 4
- Monitor for neuropsychiatric symptoms including agitation, hostility, or suicidal ideation, particularly in patients under age 24 5, 4
Cross-Titration Approach
A brief overlap period is acceptable and may reduce withdrawal symptoms:
- Week 1: Continue duloxetine 60 mg while starting bupropion 150 mg once daily
- Week 2: Reduce duloxetine to 30 mg while increasing bupropion to 150 mg twice daily
- Week 3: Discontinue duloxetine, continue bupropion 300 mg/day
This strategy is supported by evidence showing both medications can be used safely in combination 6, and switching between antidepressant classes is an effective strategy for SSRI/SNRI non-responders 7, 8.
Clinical Monitoring
Assess patient status within 1-2 weeks of initiating the switch 9:
- Monitor for emergence of withdrawal symptoms from duloxetine (dizziness, nausea, irritability)
- Assess for bupropion side effects (insomnia, agitation, dry mouth)
- Screen for worsening depression or suicidal ideation
- Check blood pressure if patient has hypertension history (duloxetine can cause BP increases; bupropion less so)
Evaluate therapeutic response at 6-8 weeks - if inadequate response, consider dose adjustment or alternative strategies 9, 10.
Evidence for This Switch Strategy
Research directly comparing duloxetine and bupropion shows both are effective second-line options with response rates of 60-70% 7. Bupropion demonstrates advantages in specific domains:
- Lower sexual dysfunction rates compared to duloxetine and SSRIs 9
- Less weight gain - bupropion associated with 0.22 kg less weight gain at 6 months compared to sertraline, while duloxetine showed 0.34 kg more weight gain 11
- Potentially lower suicide attempt rates in adolescent populations 8
Critical Pitfalls to Avoid
- Never use alternate-day dosing when tapering duloxetine - this dramatically increases withdrawal risk 2
- Do not abruptly discontinue duloxetine - always taper over at least 1 week 1
- Screen for seizure risk factors before starting bupropion - absolute contraindication if present 5, 4
- Do not exceed 300 mg/day bupropion without specialist consultation - seizure risk increases dose-dependently 4
- Avoid evening doses of bupropion - can cause insomnia due to activating properties